National Repository of Grey Literature 3 records found  Search took 0.00 seconds. 
Mitochondrial phenotype in minipig model transgenic for N-terminal part of human mutated huntingtin
Hansíková, H. ; Rodinová, M. ; Křížová, J. ; Dosoudilová, Z. ; Štufková, H. ; Bohuslavová, Božena ; Klíma, Jiří ; Juhás, Štefan ; Ellederová, Zdeňka ; Motlík, Jan ; Zeman, J.
Huntington’s disease (HD) is neurodegenerative disorder caused by an abnormal expansion of CAG repeat encoding a polyglutamine tract of huntingtin (htt). It has been postulated that mitochondria dysfunction may play significant role in the pathophysiology of the HD. But it is still not known yet in detail how mitochondria are able to cover energy needs of the cells during the progression of the HD.
Study of human NADH:ubiquinone oxidoreductase deficiency
Rodinová, Marie ; Hansíková, Hana (advisor) ; Kalous, Martin (referee)
NADH: ubiquinone oxidoreductase (complex I) is the most complicated enzyme of mitochondrial oxidative phosphorylation system (OXPHOS). Complex I is localised in the inner mitochondrial membrane and is composed of 45 subunits. Seven of them are coded by mtDNA, thirty eight subunits are coded by nDNA. Function of complex I is NADH oxidation and creation of proton gradient in intermembrane space by proton translocation. Mitochondrial disease caused by complex I defect are the most frequent OXPHOS disorders. Large-scale symptoms mostly affect organs with high energy demand like brain, muscle or heart. The aim of study was to characterize the impact of isolated complex I deficiency on cellular, enzymatic and protein level in patient-derived skin fibroblasts with m.3697G>A mutation in MTDN1 and c.[229C>T];[476C>A] mutations in NDUFS8. Both mutated subunits are parts of catalytic core of complex I. Heteroplasmy of mtDNA mutation m.3697G>A in fibroblast cells reached more than 90 %. Mitochondrial ultrastructure was disrupted in both patients compared to control. Mitochondrial network was nonhomogenous, mitochondrial ultrastructure showeed low cristae level and content of reactive oxygen species in both patients was significantly increased in comparison with control. Catalytic activity and protein level of...
Complex I of mitochondrial respiratory chain a its disorders.
Rodinová, Marie ; Kalous, Martin (referee) ; Hansíková, Hana (advisor)
NADH: ubiquinone oxidoreductase (Complex I) is a multisubunit protein complex of inner mitochondrial membrane. Complex I is the biggest and most complicated part of oxidative phosphorylation system, which is responsible for the cell ATP production. It consists of 45 subunits. 7 subunits are mitochondrial encoded, remainder 38 are nuclear encoded. NADH: ubiquinone oxidoreductase has L-shaped structure, which is built of two arms: membrane arm and matrix located peripheral arm. Complex I oxidize the NADH molecule. The electron transport is coupled with proton pumping across the inner mitochondrial membrane to intermembrane space, where proton gradient developed and which is used by ATP synthase to ATP synthesis. Deficiencies of NADH: ubiquinone oxidoreductase represent extensive, clinically and genetic heterogeneous group of mitochondrial diseases. Decrease of activity and amount of complex I, decrease of ATP production, changes of membrane potential, mitochondrial morphology and mitochondrial network and increasing of production of reactive oxygen species are found in cells with defects of NADH: ubiquinone oxidoreductase. Combination of this features lead to serious illnesses, which are almost fatal and we still haven't any useful therapy. Aim of this study is to summarize present knowledge about...

See also: similar author names
2 Rodinová, Marie
Interested in being notified about new results for this query?
Subscribe to the RSS feed.